This compound is primarily utilized in the field of bioconjugation and drug delivery systems. Its structure, featuring PEG (polyethylene glycol) spacers and Boc (tert-butyloxycarbonyl) protecting groups, makes it highly suitable for creating stable, biocompatible linkages in peptide and protein modifications. It is often employed in the development of targeted therapies, where it helps in attaching therapeutic agents to specific biomolecules, enhancing their solubility and prolonging their circulation time in the body. Additionally, it is used in the synthesis of advanced materials for biomedical applications, such as hydrogels and nanoparticles, due to its ability to improve stability and reduce immunogenicity. The compound also plays a role in research involving controlled release systems, where its properties enable precise delivery of active pharmaceutical ingredients to targeted sites.